• money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » PharmEasy

PharmEasy

  • Exclusive

    Indian unicorn's mantra

    It's not uncommon for startups, especially in rapidly evolving ecosystems like India's, to delay filing their financials for various reasons. As many

  • Exclusive

    Pharmeasy in talks with new investors for pre-IPO fund infusion

    Pharmeasy was looking to raise nearly $200 million in primary capital from investors based in the US and Southeast Asia.

  • Sunday Special

    Check out A Velumani's contrarian PF funda

    A Velumani feels an individual has to mortgage mind, heart and freedom in order to buy a house and he never felt the need to do it

  • Markets

    Thyrocare Technologies falls 8% as PharmEasy to buy majority stake

    Shares of the company traded 8.15% down at Rs 1,330 at around 11.57 am (IST). On the other hand, the benchmark BSE Sensex was down 0.23% at 52,804.

  • Exclusive

    PharmEasy to acquire 66.1% stake in Thyrocare

    Docon Technologies Pvt Ltd, a 100% subsidiary of API, will be the acquirer and shall make an open offer for an additional 26% stake

  • Exclusive

    PharmEasy acquires Medlife, creates country’s largest e-pharmacy

    As part of the deal, Medlife will cease operations and its users will be able to use their log in credentials to access the PharmEasy app

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Contact Us
  • About Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2026 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close